Form 8-K - Current report:
SEC Accession No. 0001437749-25-003490
Filing Date
2025-02-12
Accepted
2025-02-12 08:15:20
Documents
14
Period of Report
2025-02-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20250203_8k.htm   iXBRL 8-K 32250
  Complete submission text file 0001437749-25-003490.txt   168876

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20250207.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20250207_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20250207_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20250207_pre.xml EX-101.PRE 12022
16 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250203_8k_htm.xml XML 2923
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 25612101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)